Juniper Investment Company, LLC
In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 14, 2024), Juniper Investment Company, LLC reported 12 stock positions worth $239.5 million. Its top holding was Bioventus Class A (BVS) at 34.6% of the portfolio, followed by Artivion (AORT, 23.3%) and Lincoln Educational Services (LINC, 16.1%). Compared with Q2 2024, it added to 3 and reduced 3. The biggest buy was Bioventus Class A (BVS, shares +2%) and the biggest sale Vse (VSEC, shares −61%).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001794034
- Portfolio Value
- $239.5M (Q3 2024)
- SEC Filing
- 0001214659-24-019132 ↗ filed Nov 14, 2024
Holdings Value
Holdings 12 stocks · $239.5M
| BVS Bioventus Inc. Class A | 34.62% | 6,939,357 | $82.9M | Add +1.5% |
| AORT Artivion Inc. | 23.32% | 2,098,164 | $55.9M | No change |
| LINC Lincoln Educational Services | 16.14% | 3,237,451 | $38.7M | Reduce -2.5% |
| ALNT Allient Inc. | 6.01% | 758,652 | $14.4M | No change |
| OFIX Orthofix Medical Inc. | 5.65% | 866,593 | $13.5M | Add +180.2% |
| TWIN Twin Disc Inc. | 5.34% | 1,024,954 | $12.8M | No change |
| VSEC Vse Corp. | 4.16% | 120,512 | $10.0M | Reduce -61.4% |
| ALOT Astronova Inc. | 3.01% | 535,203 | $7.2M | No change |
| LYTS Lsi Industries Inc. | 0.74% | 109,811 | $1.8M | Add +22.8% |
| INTT Intest Corp. | 0.60% | 196,049 | $1.4M | Reduce -29.3% |
| XTNT Xtant Medical Holdings Inc. | 0.37% | 1,318,944 | $892K | No change |
| POCI Precision Optics Corp. Inc. | 0.04% | 15,502 | $87K | No change |
Portfolio Sells Q2 2024 → Q3 2024
Portfolio Buys Q2 2024 → Q3 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 10 | $377.5M | LINC, ALNT, BVS, AORT, OFIX |
| Q1 2026 | 8 | $313.1M | LINC, BVS, ALNT, OFIX, AORT |
| Q4 2025 | 8 | $290.9M | LINC, AORT, OFIX, BVS, ALNT |
| Q3 2025 | 9 | $261.4M | AORT, LINC, BVS, OFIX, ALNT |
| Q2 2025 | 11 | $242.6M | AORT, LINC, BVS, ALNT, OFIX |
| Q1 2025 | 11 | $221.9M | BVS, AORT, LINC, OFIX, ALNT |
| Q4 2024 | 11 | $253.5M | BVS, AORT, LINC, OFIX, ALNT |
| Q3 2024 | 12 | $239.5M | BVS, AORT, LINC, ALNT, OFIX |
| Q2 2024 | 12 | $208.6M | AORT, LINC, BVS, VSEC, ALNT |
| Q1 2024 | 10 | $201.0M | AORT, BVS, LINC, VSEC, ALNT |